Nagaoka Maki, Hashimoto Zenta, Takeuchi Hiroyoshi, Sado Mitsuhiro
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Department of Neuropsychiatry, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
PLoS One. 2021 Aug 2;16(8):e0255128. doi: 10.1371/journal.pone.0255128. eCollection 2021.
To assess the effectiveness of mindfulness-based interventions on people with dementia and mild cognitive impairment.
We searched several electronic databases, namely Cochrane Library, EMBASE, and MEDLINE with no limitations for language or document type (last search: 1 February 2020). Randomized controlled trials of mindfulness-based interventions for people with dementia and mild cognitive impairment compared to active-control interventions, waiting lists, or treatment as usual were included. Predefined outcomes were anxiety symptoms, depressive symptoms, cognitive function, quality of life, mindfulness, ADL and attrition. We used the random effects model (DerSimonian-Laird method) for meta-analysis, reporting effect sizes as Standardized Mean Difference. Heterogeneity was assessed with the I2 statistics.
Eight randomized controlled trials, involving 276 patients, met the eligibility criteria and were included in the meta-analysis. We found no significant effects for mindfulness-based interventions in either the short-term or the medium- to long-term on any outcomes, when compared with control conditions. The number of included studies and sample sizes were too small. Additionally, the quality of evidence was low for each randomized controlled trial included in the analysis. This is primarily due to lack of intent-to-treat analysis, high risk of bias, and imprecise study results. The limited statistical power and weak body of evidence prevented us from reaching firm conclusions.
We found no significant effects of mindfulness-based interventions on any of the outcomes when compared with control conditions. The evidence concerning the efficacy of mindfulness-based interventions in this population is scarce in terms of both quality and quantity. More well-designed, rigorous, and large-scale randomized controlled trials are needed.
评估基于正念的干预措施对痴呆症和轻度认知障碍患者的有效性。
我们检索了多个电子数据库,即Cochrane图书馆、EMBASE和MEDLINE,对语言或文献类型无限制(最后一次检索:2020年2月1日)。纳入了针对痴呆症和轻度认知障碍患者的基于正念的干预措施与积极对照干预、等待名单或常规治疗相比的随机对照试验。预定义的结局包括焦虑症状、抑郁症状、认知功能、生活质量、正念、日常生活活动能力和损耗。我们使用随机效应模型(DerSimonian-Laird方法)进行荟萃分析,效应大小以标准化均数差报告。异质性用I²统计量评估。
八项随机对照试验,涉及276名患者,符合纳入标准并被纳入荟萃分析。与对照条件相比,我们发现基于正念的干预措施在短期或中长期对任何结局均无显著影响。纳入研究的数量和样本量太小。此外,分析中纳入的每项随机对照试验的证据质量都很低。这主要是由于缺乏意向性分析、高偏倚风险和不精确的研究结果。有限的统计效力和薄弱的证据基础使我们无法得出确凿的结论。
与对照条件相比,我们发现基于正念的干预措施对任何结局均无显著影响。关于基于正念的干预措施在该人群中的疗效,在质量和数量方面的证据都很匮乏。需要更多设计良好、严谨且大规模的随机对照试验。